Osteoarthritis Clinical & Non-Clinical Studies, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Key Companies – Novartis, 4P Pharma, Techfields, Amplicore, Ampio, Sorrento, and Others

October 20 04:10 2021
Osteoarthritis Clinical & Non-Clinical Studies, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Key Companies - Novartis, 4P Pharma, Techfields, Amplicore, Ampio, Sorrento, and Others
Delveinsight Business Research LLP
Osteoarthritis Pipeline Insight, 2021″ report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Osteoarthritis Market.

The Osteoarthritis Pipeline report embraces in-depth commercial and clinical assessment of the Osteoarthritis pipeline products from the pre-clinical developmental phase to the marketed phase. 

The report covers a detailed description of the drug including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Osteoarthritis collaborations, mergers, acquisition, funding, designations, and other product-related details.

Osteoarthritis Therapeutics Landscape

Osteoarthritis Pipeline Analysis

The report provides insights into: 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Osteoarthritis with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the Osteoarthritis Treatment.

  • Osteoarthritis key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Osteoarthritis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Osteoarthritis market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.  

Osteoarthritis Therapeutics Landscape

Osteoarthritis Treatment can be broadly classified into a reduction of modifiable risk factors, intraarticular therapy, physical modalities, alternative therapies, and surgical treatments. Companies across the globe are diligently working toward the development of new therapies for Osteoarthritis treatment. 

The current research is looking toward the employment of effective therapies such as cell-mediated gene therapy, nonopioid pain therapies, regenerative medicines, and others. The competitive landscape for the Osteoarthritis market is set to gain steam due to improvements in the diagnosis methodologies and treatment options across the world.

Key Companies in the Osteoarthritis Market includes:

  • Novartis

  • 4P Pharma

  • Techfields Pharma 

  • Amplicore Pharma

  • Ampio Pharmaceuticals

  • Bone Therapeutics

  • Sorrento Therapeutics

  • Biosplice Therapeutics

  • Eupraxia Pharmaceuticals

  • Cellular Biomedicine Group

And many others.

The Osteoarthritis market has a promising outlook with several emerging therapies in Phase III and Phase II stages of development.

Osteoarthritis Therapies covered in the report includes:

  • AME-1101

  • 4P-004

  • LNA043

  • LRX712

  • X 0002

  • DMI 9523

  • JTA-004

  • SM04690

  • X0002

  • EP-104IAR

  • AlloJoin therapy

  • Resiniferatoxin

And many more.

Request for Sample Pages @ Osteoarthritis Emerging Therapies and Key Companies

Report Highlights

  • A better understanding of disease pathogenesis contributing to the development of novel therapeutics for Osteoarthritis.    

  • In the coming years, the Osteoarthritis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market. 

  • The companies and academics are working to assess challenges and seek opportunities that could influence Osteoarthritis Research & Development. The therapies under development are focused on novel approaches to treat/improve the disease condition.

  • A detailed portfolio of major pharma players who are involved in fueling the Osteoarthritis treatment market. Several potential therapies for Osteoarthritis are under investigation. With the expected launch of these emerging therapies, it is expected that there will be a significant impact on the Osteoarthritis market size in the coming years.  

  • Our in-depth analysis of the Osteoarthritis pipeline assets (in early-stage, mid-stage, and late stage of development) includes therapeutic assessment and comparative analysis. This will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities. 

Download sample pages @ Osteoarthritis Pipeline Landscape

Table of Content

1. Report Introduction

2. Osteoarthritis 

3. Osteoarthritis Current Treatment Patterns

4. Osteoarthritis – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Osteoarthritis Late Stage Products (Phase-III)

7. Osteoarthritis Mid Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Osteoarthritis Discontinued Products

13. Osteoarthritis Product Profiles

14. Osteoarthritis Key Companies

15. Osteoarthritis Key Products

16. Dormant and Discontinued Products

17. Osteoarthritis Unmet Needs

18. Osteoarthritis Future Perspectives

19. Osteoarthritis Analyst Review  

20. Appendix

21. Report Methodology

*The table of contents is not exhaustive; the final content may vary. 

Visit to get the sample report: https://www.delveinsight.com/sample-request/osteoarthritis-pipeline-insight

Latest Reports By DelveInsight

Muscle Atrophy/ Wasting Syndrome Market

DelveInsight’s “Muscle Atrophy/ Wasting Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Muscle Atrophy/ Wasting Syndrome market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Trending Healthcare Blog 

Digital Therapeutics (DTx) for Depression Market Trends

Globally, some of the key companies actively working in the Digital Therapeutics (DTx) for Depression Market include MindDoc, Happify Health, Otsuka Pharmaceutical, Sanvello Health, Roble Ridge Software, Touchkin eServices, Neurolief, Infinite Games, Magellan Health, Selfapy, Youper, Talkspace, Springstone, TalkLife, UpLift Health, InnerHour, Mindstrong Wallace Laboratories, Lyra Health, MoodMission, and several others. Owing to the positive outcome several new players are also expected to enter the market near future. Read More: Key Companies in Digital Therapeutics (DTx) for Depression Market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/